Molecular Pathology of Benign and Malignant Thyroid Tumors

Molecular Pathology of Benign and Malignant Thyroid Tumors - Thyroid Molecular Pathology

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010141

Enrollment

800

Registered

2016-03-15

Start date

2016-02-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C73 D35

Interventions

Group 1: Retrospective and prospective basic research study on excess tissues at disposal after surgery of patients with thyroid tumors/tissues and their lymph node and distant metastases

molecular pathology analyses (molecular genetics, proteomics, immunohistochemistry, and potentially generation of primary tissue cultures and murine xenografts).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent surgery for benign and malignant thyroid tumors (or C-cell hyperplasia)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Identification of disease-associated genes as well as expression of genes and proteins	—

Countries

Germany

Contacts

Public ContactThomas J. Musholt

Universitätsmedizin Mainz, Sektion Endokrine Chirurgie, Klinik für Allgemein-, Viszeral- u. Transplantationschirurgie

musholt@uni-mainz.de+49-6131-175117

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026